The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Vermont for multiple section 1135 flexibilities on March 30, 2020. Your follow-up communication to CMS on January 14, 2021 indicated Vermont’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of South Carolina for multiple section 1135 flexibilities on March 31, 2020. Your follow-up communication to CMS on January 14, 2021 indicated South Carolina’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Nevada for multiple section 1135 flexibilities on April 7, 2020. Your follow-up communication to CMS on January 12, 2021 indicated Nevada’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Missouri for multiple section 1135 flexibilities on March 25, 2020. Your follow-up communication to CMS on January 11, 2021 indicated Missouri’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Missouri for multiple section 1135 flexibilities on March 25, 2020. Your follow-up communication to CMS on February 16, 2021, detailed a number of additional federal requirements that also pose issues or challenges for the health care delivery system in Missouri and requested a waiver or modification of those additional requirements.

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Minnesota for multiple section 1135 flexibilities on March 27, 2020. Your follow-up communication to CMS on February 10, 2021, indicated Minnesota’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Maine for multiple section 1135 flexibilities on April 7, 2020. Your follow-up communication to CMS on February 12, 2021 indicated Maine’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).

The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Louisiana for multiple section 1135 flexibilities on March 23, 2020. Your follow-up communication to CMS on January 19, 2021 indicated Louisiana’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).